9 de noviembre de 2015 / 19:29 / en 2 años

Mallinckrodt plunges after Citron tweet

Nov 9 (Reuters) - Shares of Mallinckrodt Plc fell as much as 26 percent on Monday after short-seller Citron Research called the drugmaker “a far worse offender of the reimbursement system” in a tweet.

Citron also indicated that it would disclose more in a report. (bit.ly/1ScY0O9)

Shares of Mallinckrodt - which makes specialty drugs, medical imaging agents and generic drugs - were down 15 percent at $59.01 on the New York Stock Exchange. (Reporting by Vidya L Nathan in Bengaluru; Editing by Anil D‘Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below